Start-up funding

Our mission

Accelerate and maximize the chance of success of projects exploiting the potential of our biopolymers in new applications meeting high unmet medical needs.

We offer :

Financial support through seeds round, series A
Biopolymers science
Biopolymers CMC expertise
Connection to strategics and KOL network
Market intelligence and strategic advisory

Which projects can apply

Developing Rx drug products or medical devices at non-clinical stages or GMP technologies
With a first in vivo proof of concept
Located around the world
Seeking financial and technical support
Looking for business collaboration with HTL
Opening doors to biopolymers in new medical sectors: drug delivery, regenerative medicine, prosthetics and implants, oncology, nephrology…
Developing new benefits in HTL’s major applications: ophthalmology, reconstructive medicine, dermatology, rheumatology, bio-production…

Apply now

Working Together

Collaboration with HTL, a long-standing partner to the pharmaceutical and medical device industries worldwide, opens the door to faster business development.
HTL aims to have an impact on its portfolio companies, not only as a financial supporter, but also as a scientific, technical, industrial, commercial and strategic advisor.

Apply now

FIRST FUNDING

Discover our
first investment

In March 2022, HTL announced its incubator’s equity investment in GelMEDIX, an early-stage biotech engineering ocular cell therapies to restore vision for patients suffering from blindness.

HTL provide financial, industrial and scientific support to GelMEDIX to facilitate the development of new solutions based on its proprietary hydrogel platform.

Learn more about it